Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
AMAG PHARMACEUTICALS, INC.
| Metric | AMAG PHARMACEUTICALS, INC. Healthcare |
|---|---|
| Quality Score | 23 / 100 |
| Revenue (latest) | $76M |
| Net income (latest) | −$122M |
| Operating margin | −587.7% |
| Net margin | −161.1% |
| Return on equity | −42.7% |
| Return on assets | −15.4% |
| Return on capital (ROCE) | −76.4% |
| Debt / equity | 1.77× |
| Revenue growth (YoY) | −35.4% |
| Altman Z″ (distress) | -6.45 |
| Accruals / assets | 0.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.